Latest News
Simbec-Orion Streamlines Trial Execution With Veeva Clinical Applications
08/12/2020
Vault CTMS and Vault eTMF provide complete visibility into trials, enabling CRO to deliver value-added services to sponsors PLEASANTON, Calif.–(BUSINESS WIRE)–Veeva Systems (NYSE: VEEV) today announced that Simbec-Orion, a full-service contract research organization (CRO) specialized in clinical pharmacology, oncology, and rare diseases, is adopting Veeva Vault CTMS and Veeva Vault eTMF to digitize end-to-end clinical trial data, workflows, and documents. Veeva […]
Simbec-Orion and Oncodistinct Network agreement to strengthen early phase oncology research
01/10/2020
Providing oncology drug developers with the successful delivery of early phase oncology studies. Slough, Berkshire, United Kingdom: Simbec-Orion announced a charter agreement between the Oncodistinct Network and Simbec-Orion. The agreement strengthens the relationships between Simbec-Orion and the Oncodistinct network of oncology sites, who partner in operations and scientific expertise in the design and conduct of […]
Exvastat wins a 3.6 million euro grant for COVID-19 trial
19/05/2020
Congratulations to Cambridge Innovation Capital portfolio company Exvastat that has been awarded a grant from the prestigious Innovative Medicines Initiative. The grant will be used to reformulate and study imatinib in the treatment of Covid-19 associated Acute Respiratory Distress Syndrome (ARDS) in collaboration with Vrije Universiteit Amsterdam (VU Amsterdam), KABS Laboratories Inc. and Simbec-Orion. Read […]
Maintaining an agile and collaborative approach during the COVID-19 Pandemic
01/04/2020
Simbec-Orion COVID-19 Update 1 April 2020
Simbec-Orion Receives The “CRO Of The Year” Award At 2019 European Lifestars AwardsTM
21/01/2020
Celebrating success across life sciences London, UK, November 25th 2019. Simbec-Orion is pleased to announce that it has been recognised as the winner of the CRO of the Year award at the 2019 Lifestars AwardsTM. Lifestars is a celebration of the success stories, innovations, transformational deals and the people, teams and organisations that play such […]
